Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases.

Autor: Wei AZ; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States., Uriel M; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States., Porcu A; Department of Medical Oncology Thomas Jefferson University Hospitals, Philadelphia, PA, United States., Manos MP; Dana-Farber Cancer Institute, Boston, MA, United States., Mercurio AC; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States., Caplan MM; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States., Hulse L; Department of Medical Oncology Thomas Jefferson University Hospitals, Philadelphia, PA, United States., Seedor RS; Department of Medical Oncology Thomas Jefferson University Hospitals, Philadelphia, PA, United States., Holovatska M; Dana-Farber Cancer Institute, Boston, MA, United States., Francis J; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Khan SA; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States., McDonnell DE; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States., Bogomolny D; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States., Sato T; Department of Medical Oncology Thomas Jefferson University Hospitals, Philadelphia, PA, United States., Marr BP; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States., Haq R; Dana-Farber Cancer Institute, Boston, MA, United States., Orloff M; Department of Medical Oncology Thomas Jefferson University Hospitals, Philadelphia, PA, United States., Shoushtari A; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Carvajal RD; Division of Hematology & Oncology Columbia University Irving Medical Center, New York, NY, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2022 Sep 08; Vol. 12, pp. 961517. Date of Electronic Publication: 2022 Sep 08 (Print Publication: 2022).